Nuzenio

Partnership With Sobi

Partnership With Sobi news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Sobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSciAllSci · Mon, 10 Aug 2026 16:50:24 GMTBuy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged - TipRanksTipRanks · Mon, 10 Aug 2026 16:38:51 GMTSobi licenses lacutamab from Innate Pharma - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 15:17:30 GMTM&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 13:57:46 GMTSobi pens $580M deal for Innate’s cancer drug before ph. 3 push - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:13:48 GMTInnate Pharma (NASDAQ: IPHA) secures Sobi deal, $75M upfront and Phase 3 push - Stock TitanStock Titan · Mon, 10 Aug 2026 10:05:10 GMTSobi partners with Innate Pharma to advance lac... - PluangPluang · Mon, 10 Aug 2026 07:32:30 GMTSobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio - TipRanksTipRanks · Mon, 10 Aug 2026 06:42:09 GMT

Timeline

Mon, 10 Aug 2026 16:50:24 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSci
Mon, 10 Aug 2026 16:38:51 GMTBuy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged - TipRanks
Mon, 10 Aug 2026 15:17:30 GMTSobi licenses lacutamab from Innate Pharma - The Pharma Letter
Mon, 10 Aug 2026 13:57:46 GMTM&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo - Pharmaceutical Executive
Mon, 10 Aug 2026 11:13:48 GMTSobi pens $580M deal for Innate’s cancer drug before ph. 3 push - Fierce Biotech
Mon, 10 Aug 2026 10:05:10 GMTInnate Pharma (NASDAQ: IPHA) secures Sobi deal, $75M upfront and Phase 3 push - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Partnership With Sobi.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.